Fig. 5
From: Cancer testis antigen burden (CTAB): a novel biomarker of tumor-associated antigens in lung cancer
Kaplan–Meier (KM) overall survival and response rate analyses comparing treatment groups within cancer testis antigen burden (CTAB) high and low groups in the retrospective cohort: A KM overall survival analysis for patients with high CTAB with comparison p-value indicated, B KM overall survival analysis for patients with low CTAB with comparison p-value indicated, C response rate analysis for patients with high CTAB with Fisher’s Exact Test p-value indicated, D response rate analysis for patients with low CTAB with Fisher’s Exact Test p-value indicated